Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=false and destructiveHint=false, and the description does not contradict these. The description adds the useful context that bulk execution via ids is supported, but it does not disclose what happens when the cycle end date is changed, whether it affects the current billing period, or what side effects may occur. Still, the core write/non-destructive behavior is covered by annotations, so a middle score is appropriate.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a bloated generic template that lists every subscription mutation action, most of which are irrelevant to this specific tool. The relevant action is buried behind 13 unrelated actions, and the description is not front-loaded or tailored to this tool. The bulk-support sentence is the only concise, tool-specific addition.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

This is a write tool with an unstructured `data` object and no output schema, so the description should explain what setting the cycle end date does, what keys are expected in `data`, and what response/errors to expect. It does none of that. The bulk-support hint is a small positive, but overall the description is inadequate for an agent to invoke this tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema has 0% coverage, so the description must compensate. It indicates 'set_cycle_end_date (id + data)' and mentions bulk support, which adds some meaning to the ids parameter. However, it does not explain the structure or required fields of the free-form `data` object, and it implies data is required while the schema only requires `id`, creating potential confusion.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with a generic statement about Guru subscription mutations and lists 14 possible actions. The tool is identified only by the line '[Flattened action: set_cycle_end_date]', which merely restates the action portion of the name and does not explain that this tool changes the billing cycle end date. It does not clearly distinguish this tool from siblings like guru_subscriptions_write_set_trial_end_date.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

No guidance is given about when to use this tool versus the many sibling mutation tools. The long list of actions implies that alternatives exist, but there is no explanation of when set_cycle_end_date is appropriate, no prerequisites, and no exclusions. The only operational hint is the bulk-support note about accepting ids.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.